Pulmonology Advisor16h
FDA Grants Fast Track Status to PP-01 for Cannabis Withdrawal Syndrome
The FDA has granted Fast Track designation to PP-01 for the mitigation of cannabis withdrawal symptoms in patients with cannabis use disorder.
Ophthalmology Advisor17h
OKYO Pharma Seeks Fast Track for Urcosimod in Neuropathic Corneal Pain
OKYO Pharma has filed a Fast Track designation application for urcosimod in the treatment of neuropathic corneal pain.